Obstetrics , Prenatal Outcomes in Recurrent Miscarriage (OBPORPL)

April 4, 2024 updated by: Reem Salah Abdelkareem Ahmed, Assiut University

The Associations Between History of Recurrent Miscarriage and Obstetric and Perinatal Outcomes in the Subsequent Pregnancy

The effect of recurrent miscarriage on the outcome of the current pregnancy and if there's a relation between it and adverse out come

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Estimated)

102

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Assiut, Egypt
        • Recruiting
        • Assiut University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

patients who had ≥2 abortions during early pregnancy, patients had no abnormal reproductive tract anatomy , single fetus

Description

Inclusion Criteria:

1- patients who had ≥2 abortions during early pregnancy 2.patients had no abnormal reproductive tract anatomy 3. Pregnant in single fetus

Exclusion criteria:

chronic hypertension, chronic kidney diseases autoimmune diseases multiple pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
If there's relation between recurrent abortion and having a medical disorder during current pregnancy
Time Frame: 2023 to 2025
2023 to 2025

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 21, 2024

Primary Completion (Estimated)

March 21, 2025

Study Completion (Estimated)

March 21, 2025

Study Registration Dates

First Submitted

March 21, 2024

First Submitted That Met QC Criteria

April 4, 2024

First Posted (Actual)

April 10, 2024

Study Record Updates

Last Update Posted (Actual)

April 10, 2024

Last Update Submitted That Met QC Criteria

April 4, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe